Clinical Trials

Clinical Trials Market Research Reports

Clinical Trials Market Research Reports Analysis and Trends

Clinical trials are research studies that test how well new medical approaches work in people. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose or treat a disease. Clinical trials might compare a new treatment to a treatment that is already available.

Every clinical trial has a protocol, or action plan, for conducting the trial. The plan describes what will be done in the study, how it will be conducted, and why each part of the study is necessary. For example, doctors use clinical trials to develop new treatments for serious diseases such as cancer.

Uses of Clinical Trials

Clinical trials are performed to evaluate new drugs, medical devices such as new catheter, biologics, psychological therapies, or other interventions. Clinical trials are done before the national regulatory authority approves marketing of the drug or device, or a new dose of the drug, for use on patients.

Types of clinical trials

During the clinical trial, the investigators: recruit patients with the predetermined characteristics, administer the treatment, and collect data on the patients' health for a defined time period. These patients can be volunteers who are not paid for participating in clinical trials. These data include measurements like vital signs, concentration of the study drug in the blood, and whether the patient's health improves or not. The researchers send the data to the trial sponsor, who then analyzes the pooled data using statistical tests.

Based on researcher’s behaviour, clinical trials can be classified as observational study and interventional study.

In an observational study, the investigators observe the subjects and measure their outcomes. Whereas in an interventional study, the investigators give the research subjects a particular medicine or other intervention and compare the treated subjects to subjects who receive no treatment or standard treatment. Then the researchers measure how the subjects' health changes.

Industry Overview

Since, clinical research is the bridge between the lab and the market for new drugs, the clinical trial industry is constantly evolving, and new clinical studies are being launched at an ever-growing pace.

India's pharmaceutical market is the second largest in Asia, growing by more than 9% annually. The Indian pharmaceutical industry is estimated at US$ 5.40 billion and projected to grow up to US$ 7.40 billion. India is increasingly being recognized as a centre for global clinical trials.   

Clinical Trials Industry Current Trends

According to the reports, the Clinical Trials market worldwide is worth over US$ 45 billion and the industry has employed an estimated 2,10,000 people in the US and over 70,000 people in the UK and they  form one third of the total Research & Development staff.

As per the reports, Clinical Trial industry in India touched US$400 million in 2010, up from US$230 million in 2008 and is expected to touch US$1.09 billion by 2014. The cost of conducting clinical trials in developing countries like India and China is far lower when compared to their developed counterparts.

Major Clinical Trials Industry Players

Some of the major pharmaceutical and clinical research organizations in India are Asian Clinical Trials, Dr Reddy's Lab, Glaxo Smithkline, Igate, Periclinical, Quintiles, Lotus Labs, Ranbaxy Laboratories, Novartis, and Omnicare. 

Publication Single User License (PDF) Price
Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H1, 2015

Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H1, 2015

Date Published: Mar 31 2015

Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2015

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2015

Date Published: Mar 31 2015

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Aneurysm Global Clinical Trials Review, H1, 2015

Aneurysm Global Clinical Trials Review, H1, 2015

Date Published: Mar 31 2015

Aneurysm Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Aortic Aneurysm Global Clinical Trials Review, H1, 2015

Aortic Aneurysm Global Clinical Trials Review, H1, 2015

Date Published: Mar 31 2015

Aortic Aneurysm Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Atrial Flutter Global Clinical Trials Review, H1, 2015

Atrial Flutter Global Clinical Trials Review, H1, 2015

Date Published: Mar 31 2015

Atrial Flutter Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Cerebral Aneurysms Global Clinical Trials Review, H1, 2015

Cerebral Aneurysms Global Clinical Trials Review, H1, 2015

Date Published: Mar 31 2015

Cerebral Aneurysms Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Ventricular Fibrillation Global Clinical Trials Review, H1, 2015

Ventricular Fibrillation Global Clinical Trials Review, H1, 2015

Date Published: Mar 31 2015

Ventricular Fibrillation Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Reperfusion Injury Global Clinical Trials Review, H1, 2015

Reperfusion Injury Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Reperfusion Injury Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Salivary Gland Cancer Global Clinical Trials Review, H1, 2015

Salivary Gland Cancer Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Salivary Gland Cancer Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Bradycardia Global Clinical Trials Review, H1, 2015

Bradycardia Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Bradycardia Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Hypoxemia Global Clinical Trials Review, H1, 2015

Hypoxemia Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Hypoxemia Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Low Cardiac Output Syndrome Global Clinical Trials Review, H1, 2015

Low Cardiac Output Syndrome Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Low Cardiac Output Syndrome Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015

Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Mitral Regurgitation Global Clinical Trials Review, H1, 2015

Mitral Regurgitation Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Mitral Regurgitation Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Glomerulonephritis Global Clinical Trials Review, H1, 2015

Glomerulonephritis Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Glomerulonephritis Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Orthostatic Hypotension Global Clinical Trials Review, H1, 2015

Orthostatic Hypotension Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Orthostatic Hypotension Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Pediatric Cancer Global Clinical Trials Review, H1, 2015

Pediatric Cancer Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Pediatric Cancer Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Portal Hypertension Global Clinical Trials Review, H1, 2015

Portal Hypertension Global Clinical Trials Review, H1, 2015

Date Published: Mar 27 2015

Portal Hypertension Global Clinical Trials Review, H1, 2015

Summary

$2,500.00
Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials in China

Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials in China

Date Published: Mar 20 2015
"China’s healthcare market is indispensable for overseas and multinational pharmaceutical companies, but Chinese regulations on pharmaceutical clinical trials are undergoing sharp changes. This is first time in history, Chinese pharmaceutical authorities officially issued a guidance on international multi-center clinical trials of drugs in China, which has begun to be implemented on March 1, 2015. To enter into Chinese lucrative drug market, the overseas and multinational pharmaceutical manufacturers must be compliance with this latest regulations.
$1,495.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data